falsefalse

Integrating Molecular Testing into Decision Making in NSCLC - Episode 4

Average Turnaround Time for NSCLC Molecular Testing

, ,

Dr Neil Morganstein explains the typical turnaround times for molecular testing he sees and the challenges that prolong the process.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Challenges With and Strategies for Tissue Procurement in NSCLC
    EP. 2: Enhancing Communication Among the Multidisciplinary Care Team
    EP. 3: Best Practices for Accurate Tissue Genotyping in NSCLC
    Now Viewing
    EP. 4: Average Turnaround Time for NSCLC Molecular Testing
    EP. 5: Types of Tissue Next-Generation Sequencing Platforms in NSCLC
    EP. 6: Using Liquid Biopsy for Molecular Testing in NSCLC
    EP. 7: Integrating Molecular Testing Results into Electronic Medical Records
    EP. 8: Receiving Molecular Testing Results for NSCLC
    EP. 9: Financial Considerations with Molecular Testing for Patients With NSCLC
    EP. 10: The Future of Molecular Testing in NSCLC

    Related Content:

    Integrating Molecular Testing into Decision Making in NSCLCLung CancerInsightsInsights Video Series
    Adjuvant Aumolertinib Boosts DFS in Stage II-IIIB, EGFR-Mutated NSCLC
    Adagrasib Yields Early Efficacy in STK11- and KRAS G12C–Mutant NSCLC
    Lung Cancer Experts Highlight the Significance and Limitations of ADCs
    x